Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

scientific article

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1200/JCO.2004.09.059
P698PubMed publication ID15067028

P50authorRoberto LabiancaQ39950156
Daniel J. SargentQ43055483
Steven R AlbertsQ88846398
P2093author name stringWei Chen
Richard M Goldberg
Charles L Loprinzi
Daniel G Haller
Guido Francini
Jean Francois Seitz
Stephen S Cha
Sharlene Gill
Lois E Shepherd
Michael P Heldebrant
Stephan D Thomé
Jacqueline Benedetti
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectcolon cancerQ18555025
P304page(s)1797-1806
P577publication date2004-04-05
P1433published inJournal of Clinical OncologyQ400292
P1476titlePooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
P478volume22